These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36498655)

  • 1. Quantitative Assessment of Tumor-Infiltrating Lymphocytes Using Machine Learning Predicts Survival in Muscle-Invasive Bladder Cancer.
    Zheng Q; Yang R; Ni X; Yang S; Jiao P; Wu J; Xiong L; Wang J; Jian J; Jiang Z; Wang L; Chen Z; Liu X
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer.
    Zheng Q; Jiang Z; Ni X; Yang S; Jiao P; Wu J; Xiong L; Yuan J; Wang J; Jian J; Wang L; Yang R; Chen Z; Liu X
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms.
    Aung TN; Shafi S; Wilmott JS; Nourmohammadi S; Vathiotis I; Gavrielatou N; Fernandez A; Yaghoobi V; Sinnberg T; Amaral T; Ikenberg K; Khosrotehrani K; Osman I; Acs B; Bai Y; Martinez-Morilla S; Moutafi M; Thompson JF; Scolyer RA; Rimm DL
    EBioMedicine; 2022 Aug; 82():104143. PubMed ID: 35810563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer.
    Bai Y; Cole K; Martinez-Morilla S; Ahmed FS; Zugazagoitia J; Staaf J; Bosch A; Ehinger A; Nimeus E; Hartman J; Acs B; Rimm DL
    Clin Cancer Res; 2021 Oct; 27(20):5557-5565. PubMed ID: 34088723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers.
    Xirou V; Moutafi M; Bai Y; Nwe Aung T; Burela S; Liu M; Kimple RJ; Shabbir Ahmed F; Schultz B; Flieder D; Connolly DC; Psyrri A; Burtness B; Rimm DL
    Oral Oncol; 2024 May; 152():106750. PubMed ID: 38547779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases.
    Chatziioannou E; Roßner J; Aung TN; Rimm DL; Niessner H; Keim U; Serna-Higuita LM; Bonzheim I; Kuhn Cuellar L; Westphal D; Steininger J; Meier F; Pop OT; Forchhammer S; Flatz L; Eigentler T; Garbe C; Röcken M; Amaral T; Sinnberg T
    EBioMedicine; 2023 Jul; 93():104644. PubMed ID: 37295047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating lymphocytes predict survival in ≥ pT2 urothelial bladder cancer.
    Ledderose S; Rodler S; Eismann L; Ledderose G; Ledderose C
    Pathol Res Pract; 2022 Sep; 237():154037. PubMed ID: 35908386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy.
    Sikic D; Weyerer V; Geppert CI; Bertz S; Lange F; Taubert H; Wach S; Schmitz-Draeger BJ; Wullich B; Hartmann A; Eckstein M
    Urol Oncol; 2022 Feb; 40(2):63.e19-63.e26. PubMed ID: 34420870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High CD3D/CD4 ratio predicts better survival in muscle-invasive bladder cancer.
    Shi MJ; Meng XY; Wu QJ; Zhou XH
    Cancer Manag Res; 2019; 11():2987-2995. PubMed ID: 31114346
    [No Abstract]   [Full Text] [Related]  

  • 10. Spatial analysis of tumor-infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma.
    Xu H; Cha YJ; Clemenceau JR; Choi J; Lee SH; Kang J; Hwang TH
    J Pathol Clin Res; 2022 Jul; 8(4):327-339. PubMed ID: 35484698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
    Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
    Pruneri G; Gray KP; Vingiani A; Viale G; Curigliano G; Criscitiello C; Láng I; Ruhstaller T; Gianni L; Goldhirsch A; Kammler R; Price KN; Cancello G; Munzone E; Gelber RD; Regan MM; Colleoni M
    Breast Cancer Res Treat; 2016 Jul; 158(2):323-31. PubMed ID: 27372069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
    Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
    Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy.
    Liu S; Duan X; Xu L; Xin L; Cheng Y; Liu Q; Ye J; Zhang S; Zhang H; Zhu S; Li T; Liu Y
    Breast Cancer Res Treat; 2015 Nov; 154(2):239-49. PubMed ID: 26498019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
    Iseki Y; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    PLoS One; 2018; 13(4):e0192744. PubMed ID: 29698402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast.
    Toss MS; Miligy I; Al-Kawaz A; Alsleem M; Khout H; Rida PC; Aneja R; Green AR; Ellis IO; Rakha EA
    Mod Pathol; 2018 Aug; 31(8):1226-1236. PubMed ID: 29559742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-Slide Image Analysis Reveals Quantitative Landscape of Tumor-Immune Microenvironment in Colorectal Cancers.
    Yoo SY; Park HE; Kim JH; Wen X; Jeong S; Cho NY; Gwon HG; Kim K; Lee HS; Jeong SY; Park KJ; Han SW; Kim TY; Bae JM; Kang GH
    Clin Cancer Res; 2020 Feb; 26(4):870-881. PubMed ID: 31757879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy.
    Murakami Y; Matsumoto K; Shimizu Y; Ikeda M; Amano N; Shimura S; Ishii D; Sato Y; Iwamura M
    Urol Oncol; 2021 Mar; 39(3):195.e15-195.e23. PubMed ID: 33071109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    In Vivo; 2018; 32(1):151-158. PubMed ID: 29275313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
    Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
    J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.